Fig. 4From: Diagnostic performance of automated, streamlined, daily updated exome analysis in patients with neurodevelopmental delayThe number of patients with newly reclassified variants (red line) and the number of newly reclassified variants (blue line) based on daily reanalysis data from April 2019 to October 2021Back to article page